Eton Pharmaceuticals, Inc.
For the period ended Nov 5, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 5, 2026 · Filed Nov 5, 2026
ETON$56.46+19.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Contraindication
Contraindication
Hypersensitivity to zinc acetate or any of the ingredients in GALZIN.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.